Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded
- Contract number
- SPE2DB26FQ86J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,576
Award facts
- Contract value 100% obligated
- $4,575.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Actemra ActPen 162 mg/0.9 mL auto-injectors with a ceiling value of $4,575.76. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The award is issued from the company's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 vehicle through December 2026 that serves as the primary pharmaceutical supply mechanism for military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company has established itself as a key vendor within the Defense Logistics Agency's medical supply chain, delivering a comprehensive range of pharmaceutical products including specialty medications, vaccines, and medical devices across multiple therapeutic domains. Actemra (tocilizumab) is a biologic immunosuppressant used primarily for rheumatoid arthritis treatment, with this delivery order supporting ongoing pharmaceutical requirements within the military healthcare system.
Quick answers
Who was awarded contract SPE2DB26FQ86J?
SPE2DB26FQ86J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FQ86J worth?
The government has obligated $4,576 on SPE2DB26FQ86J.
Is contract SPE2DB26FQ86J an order under another contract?
Yes. SPE2DB26FQ86J is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ86J competed?
The extent of competition for SPE2DB26FQ86J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award